RxDoctor Payments Data

Suzanne Yount, PA

Medical · East Bernstadt, KYNPI 1164534152

Payments from drug & device makers

$565in general payments, 2019–2025

Across 34 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$80
  • AbbVie$78
  • Lilly USA, LLC$70
  • Pfizer$57
  • Abbott$57
  • Novo Nordisk$46
  • plus $176 from 9 others

What the payments were for

  • Food & beverage$565100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$565 in reported general payments places this provider in the 45th percentile of 222 medical providers in Kentucky.

See all medical providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,682
Medicare patients
58
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate213$188,111
FarxigaDapagliflozin Propanediol199$177,284
EliquisApixaban114$97,940
MounjaroTirzepatide69$73,354
JardianceEmpagliflozin86$67,503
OzempicSemaglutide60$60,317
XareltoRivaroxaban24$25,123
TradjentaLinagliptin22$12,883
Humalog Kwikpen U-100Insulin Lispro39$11,144
Victoza 3-PakLiraglutide14$9,521
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$8,383
Albuterol Sulfate HfaAlbuterol Sulfate201$6,487
Lantus SolostarInsulin Glargine,hum.Rec.Anlog69$6,113
DapagliflozinDapagliflozin Propanediol12$5,741
SymbicortBudesonide/Formoterol Fumarate20$5,357

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$80$182,641219 claims
PfizerEliquis, Premarin$57$100,085125 claims
Boehringer IngelheimJardiance, Tradjenta$28$80,385108 claims
Lilly USA, LLCMounjaro$70$73,35469 claims
Novo NordiskOzempic, Levemir, Novolog$46$65,24895 claims
Sanofi-aventis U.S. LLCLantus$30$3,59917 claims
AbbVieSynthroid$78$1,77133 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 222 medical providers in Kentucky.

Other medical in East Bernstadt

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →